Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

The 20 Most-Frequently Read Articles
Category: All

in J Clin Oncol during July 2016 -- updated monthly

Most-read rankings are recalculated at the beginning of the month and are based on abstract, full-text and pdf views.

1.  Rita Nanda, Laura Q.M. Chow, E. Claire Dees, Raanan Berger, Shilpa Gupta, Ravit Geva, Lajos Pusztai, Kumudu Pathiraja, Gursel Aktan, Jonathan D. Cheng, Vassiliki Karantza, Laurence Buisseret
  Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study
  J Clin Oncol Jul 20, 2016; 34: 2460-2467.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
2.  Neelima Denduluri, Mark R. Somerfield, Andrea Eisen, Jamie N. Holloway, Arti Hurria, Tari A. King, Gary H. Lyman, Ann H. Partridge, Melinda L. Telli, Maureen E. Trudeau, Antonio C. Wolff
  Selection of Optimal Adjuvant Chemotherapy Regimens for Human Epidermal Growth Factor Receptor 2 (HER2) –Negative and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline
  J Clin Oncol Jul 10, 2016; 34: 2416-2427.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
3.  Jorge E. Cortes, Giuseppe Saglio, Hagop M. Kantarjian, Michele Baccarani, Jiří Mayer, Concepción Boqué, Neil P. Shah, Charles Chuah, Luis Casanova, Brigid Bradley-Garelik, George Manos, Andreas Hochhaus
  Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
  J Clin Oncol Jul 10, 2016; 34: 2333-2340.
(In "Hematologic Malignancies")   [Abstract]     [Full Text]     [PDF]
 
4.  Scott Gettinger, Naiyer A. Rizvi, Laura Q. Chow, Hossein Borghaei, Julie Brahmer, Neal Ready, David E. Gerber, Frances A. Shepherd, Scott Antonia, Jonathan W. Goldman, Rosalyn A. Juergens, Scott A. Laurie, Faith E. Nathan, Yun Shen, Christopher T. Harbison, Matthew D. Hellmann
  Nivolumab Monotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
  J Clin Oncol Jun 27, 2016; doi: 10.1200/JCO.2016.66.9929.
(In "Immunotherapy")   [Abstract]     [Full Text]     [PDF]
 
5.  Edward P. Balaban, Pamela B. Mangu, Alok A. Khorana, Manish A. Shah, Somnath Mukherjee, Christopher H. Crane, Milind M. Javle, Jennifer R. Eads, Peter Allen, Andrew H. Ko, Anitra Engebretson, Joseph M. Herman, John H. Strickler, Al B. Benson, Susan Urba, Nelson S. Yee
  Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
  J Clin Oncol Aug 01, 2016; 34: 2654-2668.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
6.  Judith A. Paice, Russell Portenoy, Christina Lacchetti, Toby Campbell, Andrea Cheville, Marc Citron, Louis S. Constine, Andrea Cooper, Paul Glare, Frank Keefe, Lakshmi Koyyalagunta, Michael Levy, Christine Miaskowski, Shirley Otis-Green, Paul Sloan, Eduardo Bruera
  Management of Chronic Pain in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
  J Clin Oncol Jul 25, 2016; doi: 10.1200/JCO.2016.68.5206.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
7.  Alok A. Khorana, Pamela B. Mangu, Jordan Berlin, Anitra Engebretson, Theodore S. Hong, Anirban Maitra, Supriya G. Mohile, Matthew Mumber, Richard Schulick, Marc Shapiro, Susan Urba, Herbert J. Zeh, Matthew H.G. Katz
  Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
  J Clin Oncol Jul 20, 2016; 34: 2541-2556.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
8.  Andrew S. Epstein, Holly G. Prigerson, Eileen M. O’Reilly, Paul K. Maciejewski
  Discussions of Life Expectancy and Changes in Illness Understanding in Patients With Advanced Cancer
  J Clin Oncol Jul 10, 2016; 34: 2398-2403.
(In "Palliative and Supportive Care")   [Abstract]     [Full Text]     [PDF]
 
9.  Arti Hurria, Supriya Mohile, Ajeet Gajra, Heidi Klepin, Hyman Muss, Andrew Chapman, Tao Feng, David Smith, Can-Lan Sun, Nienke De Glas, Harvey Jay Cohen, Vani Katheria, Caroline Doan, Laura Zavala, Abrahm Levi, Chie Akiba, William P. Tew
  Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer
  J Clin Oncol Jul 10, 2016; 34: 2366-2371.
(In "Clinical Trials")   [Abstract]     [Full Text]     [PDF]
 
10.  W. Robert Lee, James J. Dignam, Mahul B. Amin, Deborah W. Bruner, Daniel Low, Gregory P. Swanson, Amit B. Shah, David P. D’Souza, Jeff M. Michalski, Ian S. Dayes, Samantha A. Seaward, William A. Hall, Paul L. Nguyen, Thomas M. Pisansky, Sergio L. Faria, Yuhchyau Chen, Bridget F. Koontz, Rebecca Paulus, Howard M. Sandler
  Randomized Phase III Noninferiority Study Comparing Two Radiotherapy Fractionation Schedules in Patients With Low-Risk Prostate Cancer
  J Clin Oncol Jul 10, 2016; 34: 2325-2332.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
11.  Naiyer A. Rizvi, Matthew D. Hellmann, Julie R. Brahmer, Rosalyn A. Juergens, Hossein Borghaei, Scott Gettinger, Laura Q. Chow, David E. Gerber, Scott A. Laurie, Jonathan W. Goldman, Frances A. Shepherd, Allen C. Chen, Yun Shen, Faith E. Nathan, Christopher T. Harbison, Scott Antonia
  Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non–Small-Cell Lung Cancer
  J Clin Oncol Jun 27, 2016; doi: 10.1200/JCO.2016.66.9861.
(In "Immunotherapy")   [Abstract]     [Full Text]     [PDF]
 
12.  Philippe Armand, Margaret A. Shipp, Vincent Ribrag, Jean-Marie Michot, Pier Luigi Zinzani, John Kuruvilla, Ellen S. Snyder, Alejandro D. Ricart, Arun Balakumaran, Shelonitda Rose, Craig H. Moskowitz
  Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure
  J Clin Oncol Jun 27, 2016; doi: 10.1200/JCO.2016.67.3467.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
13.  Hope S. Rugo, R. Bryan Rumble, Erin Macrae, Debra L. Barton, Hannah Klein Connolly, Maura N. Dickler, Lesley Fallowfield, Barbara Fowble, James N. Ingle, Mohammad Jahanzeb, Stephen R.D. Johnston, Larissa A. Korde, James L. Khatcheressian, Rita S. Mehta, Hyman B. Muss, Harold J. Burstein
  Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
  J Clin Oncol Jun 20, 2016; doi: 10.1200/JCO.2016.67.1487.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
14.  Maura N. Dickler, William T. Barry, Constance T. Cirrincione, Matthew J. Ellis, Mary Ellen Moynahan, Federico Innocenti, Arti Hurria, Hope S. Rugo, Diana E. Lake, Olwen Hahn, Bryan P. Schneider, Debasish Tripathy, Lisa A. Carey, Eric P. Winer, Clifford A. Hudis
  Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
  J Clin Oncol Aug 01, 2016; 34: 2602-2609.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
15.  Geoffrey R. Oxnard, Kenneth S. Thress, Ryan S. Alden, Rachael Lawrance, Cloud P. Paweletz, Mireille Cantarini, James Chih-Hsin Yang, J. Carl Barrett, Pasi A. Jänne
  Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non–Small-Cell Lung Cancer
  J Clin Oncol Jun 27, 2016; doi: 10.1200/JCO.2016.66.7162.
(In "Rapid Communications")   [Abstract]     [Full Text]     [PDF]
 
16.  Clémentine Sarkozy, Marek Trneny, Luc Xerri, Nick Wickham, Pierre Feugier, Sirpa Leppa, Pauline Brice, Pierre Soubeyran, Maria Gomes Da Silva, Christiane Mounier, Fritz Offner, Jehan Dupuis, Dolores Caballero, Danielle Canioni, Marlton Paula, Richard Delarue, Pierre Zachee, John Seymour, Gilles Salles, Hervé Tilly
  Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial
  J Clin Oncol Aug 01, 2016; 34: 2575-2582.
(In "Hematologic Malignancies")   [Abstract]     [Full Text]     [PDF]
 
17.  Carolyn D. Runowicz, Corinne R. Leach, N. Lynn Henry, Karen S. Henry, Heather T. Mackey, Rebecca L. Cowens-Alvarado, Rachel S. Cannady, Mandi L. Pratt-Chapman, Stephen B. Edge, Linda A. Jacobs, Arti Hurria, Lawrence B. Marks, Samuel J. LaMonte, Ellen Warner, Gary H. Lyman, Patricia A. Ganz
  American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline
  J Clin Oncol Feb 20, 2016; 34: 611-635.
(In "ASCO SPECIAL ARTICLES")   [Abstract]     [Full Text]     [PDF]
 
18.  Elena I. Pentsova, Ronak H. Shah, Jiabin Tang, Adrienne Boire, Daoqi You, Samuel Briggs, Antonio Omuro, Xuling Lin, Martin Fleisher, Christian Grommes, Katherine S. Panageas, Fanli Meng, S. Duygu Selcuklu, Shahiba Ogilvie, Natalie Distefano, Larisa Shagabayeva, Marc Rosenblum, Lisa M. DeAngelis, Agnes Viale, Ingo K. Mellinghoff
  Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
  J Clin Oncol Jul 10, 2016; 34: 2404-2415.
(In "BIOLOGY OF NEOPLASIA")   [Abstract]     [Full Text]     [PDF]
 
19.  Tari A. King, Jaclyn P. Lyman, Mithat Gonen, Amy Voci, Marina De Brot, Camilla Boafo, Amy Pratt Sing, E. Shelley Hwang, Michael D. Alvarado, Minetta C. Liu, Judy C. Boughey, Kandace P. McGuire, Catherine H. Van Poznak, Lisa K. Jacobs, Ingrid M. Meszoely, Helen Krontiras, Gildy V. Babiera, Larry Norton, Monica Morrow, Clifford A. Hudis
  Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013
  J Clin Oncol Jul 10, 2016; 34: 2359-2365.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
20.  Oleg Gluz, Ulrike A. Nitz, Matthias Christgen, Ronald E. Kates, Steven Shak, Michael Clemens, Stefan Kraemer, Bahriye Aktas, Sherko Kuemmel, Toralf Reimer, Manfred Kusche, Volker Heyl, Fatemeh Lorenz-Salehi, Marianne Just, Daniel Hofmann, Tom Degenhardt, Cornelia Liedtke, Christer Svedman, Rachel Wuerstlein, Hans H. Kreipe
  West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment
  J Clin Oncol Jul 10, 2016; 34: 2341-2349.
(In "Breast Cancer")   [Abstract]     [Full Text]     [PDF]
 
  
rss gif Subscribe to Most Read feed

Last Updated: 08/04/2016 16:18:41

About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2016 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online